A Review of the Nonmedical Use of Ketamine: Use, Users and Consequences

Abstract Ketamine is a dissociative anesthetic with an accepted place in human medicine. Ketamine also has psychedelic properties, and there has been a recent increase in nonmedical use linked with the growth of the “dance culture.” This has attracted little comment in the formal literature but has been the subject of many reports in the media. Myths and misunderstandings are common. The psychedelic properties of ketamine have also led to its use as an adjunct to psychotherapy. This review is intended as a resource for the wide range of persons now requesting accurate information about the nonmedical use of ketamine. It accepts the current necessity of sometimes referring to anecdotal reports while seeking to encourage an increase in formal research. The review includes the history of ketamine, its growing role as a “dance drug,” the sought-after effects (including the neardeath experience) for which it is taken in a nonmedical context, how these are produced, common mental and physical adverse effects, and the ketamine model of schizophrenia.

[1]  M. Sabom Recollections of Death: A Medical Investigation , 1981 .

[2]  A. Matsuki,et al.  Uneventful total intravenous anaesthesia with ketamine for schizophrenic surgical patients. , 1997, European journal of anaesthesiology.

[3]  K. Jansen Ketamine--can chronic use impair memory? , 1990, The International journal of the addictions.

[4]  C. Morgan,et al.  Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later. , 2000, Addiction.

[5]  H. Emrich,et al.  Psychotomimesis mediated by kappa opiate receptors , 1986, Science.

[6]  Awareness during general anaesthesia--incidence, clinical relevance and monitoring. , 1997, Acta anaesthesiologica Scandinavica. Supplementum.

[7]  W. Abruzzi Drug-induced psychosis , 1980 .

[8]  The apolipoprotein E epsilon 4 allele is associated with blunting of ketamine-induced psychosis in schizophrenia. A preliminary report. , 1998, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[9]  R. Faull,et al.  Immediate-early genes, kindling and long-term potentiation , 1989, Neuroscience & Biobehavioral Reviews.

[10]  Ketamine abuse , 2016, Reactions Weekly.

[11]  Carol A. Tamminga,et al.  Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia , 1995, Neuropsychopharmacology.

[12]  M E Durieux,et al.  Synergistic Inhibition of Muscarinic Signaling by Ketamine Stereoisomers and the Preservative Benzethonium Chloride , 1997, Anesthesiology.

[13]  W. Carpenter The schizophrenia ketamine challenge study debate , 1999, Biological Psychiatry.

[14]  J. Olney,et al.  NMDA antagonist neurotoxicity: mechanism and prevention. , 1991, Science.

[15]  K. Jansen,et al.  Neuroscience and the near-death experience: roles for the NMSA-PCP receptor, the sigma receptor and the endopsychosins. , 1990, Medical hypotheses.

[16]  J. Olney,et al.  Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity , 1996, Schizophrenia Research.

[17]  Moussa Awuonda Swedes alarmed at ketamine misuse , 1996, The Lancet.

[18]  J. Bakalar,et al.  Psychedelic Drugs Reconsidered , 1979 .

[19]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[20]  Bita Moghaddam,et al.  Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex , 1997, The Journal of Neuroscience.

[21]  K. Jansen Non-medical use of ketamine. , 1993, BMJ.

[22]  D. Rogo Ketamine and the Near-Death Experience , 1984 .

[23]  B. Tranmer,et al.  Postischemic therapy with MK-801 (dizocilpine) in a primate model of transient focal brain ischemia. , 1996, Molecular and chemical neuropathology.

[24]  D. Corbett Ketamine blocks the plasticity associated with prefrontal cortex self-stimulation , 1990, Pharmacology Biochemistry and Behavior.

[25]  B. Moghaddam Recent basic findings in support of excitatory amino acid hypotheses of schizophrenia , 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[26]  J. Gill,et al.  Ketamine in non-hospital and hospital deaths in New York City. , 2000, Journal of forensic sciences.

[27]  S. Rothrock,et al.  Intramuscular ketamine for pediatric sedation in the emergency department: safety profile in 1,022 cases. , 1998, Annals of emergency medicine.

[28]  J. Smith,et al.  Respiratory arrest following intramuscular ketamine injection in a 4-year-old child. , 1993, Annals of emergency medicine.

[29]  J. Olney,et al.  Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. , 1989, Science.

[30]  J. Clements,et al.  Pharmacokinetics and analgesic effects of i.m. and oral ketamine. , 1982, British journal of anaesthesia.

[31]  D G Lambert,et al.  Ketamine: its mechanism(s) of action and unusual clinical uses. , 1996, British journal of anaesthesia.

[32]  W. Adams,et al.  The brain drain. , 1969, Journal of the Irish Medical Association.

[33]  A. Thomson,et al.  An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine? , 1985, Nature.

[34]  Donn W Ketcham Where there is no Anaesthesiologist: The Many Uses of Ketamine , 1990, Tropical doctor.

[35]  J. Olney,et al.  Serotonergic Agents That Activate 5HT2A Receptors Prevent NMDA Antagonist Neurotoxicity , 1998, Neuropsychopharmacology.

[36]  F. Servin,et al.  Ketamine and norketamine plasma concentrations after i.v., nasal and rectal administration in children. , 1996, British journal of anaesthesia.

[37]  Nolan Miller,et al.  The Scientist: A Novel Autobiography , 1978 .

[38]  Anil K Malhotra,et al.  Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics , 1997, Neuropsychopharmacology.

[39]  B. Hope Cocaine and the AP‐1 Transcription Factor Complex , 1998, Annals of the New York Academy of Sciences.

[40]  J. Coyle The Nagging Question of the Function ofN-Acetylaspartylglutamate , 1997, Neurobiology of Disease.

[41]  J. Mussini,et al.  Is Ketamine or Its Preservative Responsible for Neurotoxicity in the Rabbit? , 1993, Anesthesiology.

[42]  D. Choi,et al.  Ketamine protects cultured neocortical neurons from hypoxic injury , 1986, Brain Research.

[43]  D. Hunt Pulse Check: National Trends in Drug Abuse. , 1997 .

[44]  T. Gordh,et al.  Histopathology after repeated intrathecal injections of preservative-free ketamine in the rabbit: a light and electron microscopic examination. , 1994, Anesthesia and analgesia.

[45]  G. Hempelmann,et al.  The effects of thiopentone, etomidate, ketamine and midazolam on several bactericidal functions of polymorphonuclear leucocytes in vitro. , 1995, European journal of anaesthesiology.

[46]  A. Malhotra,et al.  The Apolipoprotein E ε4 Allele Is Associated with Blunting of Ketamine-Induced Psychosis in Schizophrenia: A Preliminary Report , 1998, Neuropsychopharmacology.

[47]  T. Honoré,et al.  Phencyclidine analogues inhibit NMDA-stimulated [3H]GABA release from cultured cortex neurons. , 1987, European journal of pharmacology.

[48]  K. L. Leenders,et al.  Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET) , 1997, European Neuropsychopharmacology.

[49]  V. Grover,et al.  The effect of music on ketamine induced emergence phenomena , 1992, Anaesthesia.

[50]  R. Beninger,et al.  Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid , 1997, Neuroscience.

[51]  N. Lindefors,et al.  Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex , 1997, Brain Research.

[52]  M. Morgan,et al.  Effects of Droperidol and Nitrazepam on Emergence Reactions Following Ketamine Anesthesia , 1973, Anesthesia and analgesia.

[53]  S. Zielmann,et al.  [The effects of long-term sedation on intestinal function]. , 1995, Der Anaesthesist.

[54]  G. Plourde,et al.  Ketamine increases the amplitude of the 40-Hz auditory steady-state response in humans. , 1997, British journal of anaesthesia.

[55]  D. Gore,et al.  Superiority of oral ketamine as an analgesic and sedative for wound care procedures in the pediatric patient with burns. , 1997, The Journal of burn care & rehabilitation.

[56]  G. Pierini,et al.  A fatal ketamine poisoning. , 1994, Journal of forensic sciences.

[57]  L. Favalli,et al.  Influence of different anaesthetics on extracellular aminoacids in rat brain , 2000, Journal of Neuroscience Methods.

[58]  Olney Jw NEUROTOXICITY OF NMDA RECEPTOR ANTAGONISTS : AN OVERVIEW , 1994 .

[59]  Kenjiro Mori,et al.  Halothane and Diazepam Inhibit Ketamine‐induced c‐fos Expression in the Rat Cingulate Cortex , 1996, Anesthesiology.

[60]  S. Zukin,et al.  Adverse reactions to ketamine Anaesthesia , 1981, Anaesthesia.

[61]  B. A. van der Kolk The psychobiology of posttraumatic stress disorder. , 1997, The Journal of clinical psychiatry.

[62]  C. E. Reier Ketamine--"dissociative agent" or hallucinogen? , 1971, The New England journal of medicine.

[63]  E. Domino,et al.  Pharmacologic effects of CI‐581, a new dissociative anesthetic, in man , 1965, Clinical pharmacology and therapeutics.

[64]  N. Maekawa,et al.  The Inhibitory Effects of Thiopental, Midazolam, and Ketamine on Human Neutrophil Functions , 1998, Anesthesia and analgesia.

[65]  R. Strassman ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE , 1984, The Journal of nervous and mental disease.

[66]  K. Sato,et al.  Ketamine stereoselectively inhibits rat dopamine transporter , 1999, Neuroscience Letters.

[67]  D. Cyril D’Souza,et al.  Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans , 1998, Psychopharmacology.

[68]  A. Ganong,et al.  Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity. , 1988, Annual review of neuroscience.

[69]  K. Williams,et al.  Up-regulation of N-methyl-D-aspartate receptors on cultured cortical neurons after exposure to antagonists. , 1992, Molecular pharmacology.

[70]  J. Olney,et al.  Excitotoxity and the NMDA receptor , 1987, Trends in Neurosciences.

[71]  I. Feinberg,et al.  Observations on delta homeostasis, the one-stimulus model of NREM-REM alternation and the neurobiologic implications of experimental dream studies , 1995, Behavioural Brain Research.

[72]  T. Schorn,et al.  Are there long-term effects of ketamine on the central nervous system? , 1980, British journal of anaesthesia.

[73]  H. Benveniste,et al.  Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis , 1984, Journal of neurochemistry.

[74]  P Grimes,et al.  Acute reversible cataract induced by xylazine and by ketamine-xylazine anesthesia in rats and mice. , 1986, Experimental eye research.

[75]  P. A. Taylor,et al.  Depression of Laryngeal Reflexes during Ketamine Anaesthesia , 1971, British medical journal.

[76]  A. Maurset,et al.  Interaction of the chiral forms of ketamine with opioid, phencyclidine, σ and muscarinic receptors , 1995 .

[77]  J. White,et al.  Pharmacological properties of ketamine. , 1996, Drug and alcohol review.

[78]  T. Kudo,et al.  Effects of Ketamine on Adrenocortical Function in Man , 1970, Anesthesia and analgesia.

[79]  T. Hilden,et al.  The psychotropic effect of ketamine. , 1988, Journal of psychoactive drugs.

[80]  Takao Shimizu,et al.  Ketamine-induced hyperlocomotion associated with alteration of presynaptic components of dopamine neurons in the nucleus accumbens of mice , 1991, Pharmacology Biochemistry and Behavior.

[81]  A. Perel,et al.  Recurrent hallucinations following ketamine , 1976, Anaesthesia.

[82]  K. Jansen Near death experience and the NMDA receptor. , 1989, BMJ.

[83]  A. Weil,et al.  Chocolate to Morphine: Understanding Mind-Active Drugs , 1983 .

[84]  Herbert Weingartner,et al.  NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers , 1996, Neuropsychopharmacology.

[85]  James V. Hinrichs,et al.  Ketamine: behavioral effects of subanesthetic doses. , 1984, Journal of clinical psychopharmacology.

[86]  P Hejja,et al.  A consideration of ketamine dreams , 1975, Canadian Anaesthetists' Society journal.

[87]  L. Hokin,et al.  Lithium stimulates glutamate "release" and inositol 1,4,5-trisphosphate accumulation via activation of the N-methyl-D-aspartate receptor in monkey and mouse cerebral cortex slices. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[88]  S. Finestone,et al.  Sensory Disturbances Following Ketamine Anesthesia: Recurrent Hallucinations , 1973, Anesthesia and analgesia.

[89]  G. Ellison The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias , 1995, Brain Research Reviews.

[90]  D. Shewan,et al.  Illicit use of ketamine in Scotland. , 1996, Journal of psychoactive drugs.

[91]  W. Engelhardt [Recovery and psychomimetic reactions following S-(+)-ketamine]. , 1997, Der Anaesthesist.

[92]  J. Krystal,et al.  Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. , 2000, Archives of general psychiatry.

[93]  J. Ryan,et al.  Ketamine Does Not Trigger Malignant Hyperthermia in Susceptible Swine , 1989, Anesthesia and analgesia.

[94]  B. Chraemmer-jørgensen,et al.  PSYCHOMIMETIC REACTIONS AFTER LOW-DOSE KETAMINE INFUSION Comparison with neuroleptanaesthesia , 1983 .

[95]  R. Faull,et al.  Excitatory amino acid receptors in the human cerebral cortex: A quantitative autoradiographic study comparing the distributions of [3H]TCP, [3H]glycine,l-[3H]glutamate, [3H]AMPA and [3H]kainic acid binding sites , 1989, Neuroscience.

[96]  R. Petersen,et al.  Ketamine: behavioral effects of subanesthetic doses. , 1985, Journal of clinical psychopharmacology.

[97]  F. M. Borgbjerg,et al.  Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord. , 1997, European journal of pharmacology.

[98]  A. Matsuki,et al.  Arterial hypoxemia caused by intravenous ketamine. , 1976 .

[99]  Rex Y. Wang,et al.  M100907, A Selective 5-HT2A Receptor Antagonist and a Potential Antipsychotic Drug, Facilitates N-Methyl-D-Aspartate–Receptor Mediated Neurotransmission in the Rat Medial Prefrontal Cortical Neurons In Vitro , 1998, Neuropsychopharmacology.

[100]  E. Krupitsky,et al.  Ketamine psychedelic therapy (KPT): a review of the results of ten years of research. , 1997, Journal of psychoactive drugs.

[101]  F. Vollenweider,et al.  Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG) , 1997, European Neuropsychopharmacology.

[102]  M. Murphy,et al.  Ketamine in the ED: medical politics versus patient care. , 1999, The American journal of emergency medicine.

[103]  John H Krystal,et al.  Antidepressant effects of ketamine in depressed patients , 2000, Biological Psychiatry.

[104]  ARVIND G. BHAGWAT,et al.  Brain Drain , 1971, Nature.

[105]  J. Felser,et al.  Dystonic reaction after ketamine abuse. , 1982, Annals of emergency medicine.

[106]  G. Thompson Ketamine-induced convulsions. , 1972, Anesthesiology.

[107]  B. Moghaddam,et al.  NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[108]  W. Engelhardt Aufwachverhalten und psychomimetische Reaktionen nach S-(+)-Ketamin , 1997, Der Anaesthesist.

[109]  J. Bostwick,et al.  Ketamine dependence in anesthesia providers. , 1999, Psychosomatics.

[110]  C. McKay,et al.  Ketamine abusers presenting to the emergency department: a case series. , 2000, The Journal of emergency medicine.

[111]  F. Sharp,et al.  Neuronal injury produced by NMDA antagonists can be detected using heat shock proteins and can be blocked with antipsychotics. , 1994, Psychopharmacology bulletin.

[112]  A. E. Slaby,et al.  Handbook of Psychiatric Emergencies , 1986 .

[113]  Hurt Ph,et al.  A case of ketamine dependence. , 1994 .

[114]  S. F. Nielsen,et al.  Psychological Changes in Children after Anaesthesia: A Comparison between Halothane and Ketamine , 1977, Acta anaesthesiologica Scandinavica.

[115]  A. Artru,et al.  Effect of magnesium given 1 hour after head trauma on brain edema and neurological outcome. , 1996, Journal of neurosurgery.

[116]  A. Malhotra,et al.  Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. , 1999, The American journal of psychiatry.

[117]  K. Jansen The Ketamine Model of the Near-Death Experience: A Central Role for the N-Methyl-D-Aspartate Receptor , 1997 .

[118]  H. Kimura,et al.  High-dose ketamine does not induce c-Fos protein expression in rat hippocampus , 1993, Neuroscience Letters.

[119]  J. Olney Neurotoxicity of NMDA receptor antagonists: an overview. , 1994, Psychopharmacology bulletin.